Post by Avantor

Yesterday at #BIO2026, we had the privilege of hosting the panel discussion, "Advancing Next-Gen Biomanufacturing Across Modalities: Insights on Flexible, Resilient, and Sustainable Scale-Up.” Moderated by Nandu Deorkar, Ph.D., Senior Vice President, Research & Development, Avantor®, the session brought together industry leaders to explore how organizations are navigating the evolving biomanufacturing landscape and advancing scalable solutions across therapeutic modalities. As new therapies move from discovery to commercialization, the industry faces increasing demands for flexibility, resilience and sustainable scale-up. It was an insightful discussion that examined the strategies, technologies and partnerships helping biopharma innovators accelerate development, optimize manufacturing and prepare for the future of therapeutic production. Together, we're helping enable the next generation of scientific innovation and bringing life-changing therapies closer to patients.